It is expected that once EVs from various cancer cells can be produced in quantities suitable for the above structural studies, we will be able to see further insight into mechanistic details of membrane-active compounds and, in particular, identify which types of cell membranes have the highest affinity to bind certain ACPs, aiding the identification of their optimal application areas. Here, AASDHPPT is linked to cancer.